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http://intl.elsevierhealth.com/journals/ijidElectrolyte disturbances may predispose
nucleoside analogue-treated AIDS patients
to acute renal failure
confirmed Isospora belli.Acute renal failure (ARF) is common in AIDS
patients. Acute tubular necrosis due to hemody-
namic and toxic injury is the most common cause
of acute renal failure (ARF) in HIV-infected
patients.1,2 Nucleoside and nucleotide analogues
can lead to mitochondrial dysfunction and cellular
toxicity. Although these drugs are unchanged upon
excretion from the kidney, mitochondrial toxicity at
this site has not been described. Recently, it has
been shown that hypokalemia and hypomagnese-
mia, two metabolic disturbances frequently seen
in AIDS patients, predispose rats treated with zido-
vudine and didanosine to ARF.3 Here, a case of ARF
associated with hypokalemia and severe hypomag-
nesemia is described in an AIDS patient receiving
two nucleoside analogues. In this case, the ARF
resolved concomitantly with the correction of the
electrolyte disturbances.
A 37-year-old white man who had been infected
with HIV for six years was admitted to hospital with
persistent diarrhea and, since the day before,
malaise and decreased urine output The patient
was taking stavudine, lamivudine and efavirenz.
The patient had previously been treated with sulfa-
methoxazole-trimethoprim as a stool culture had
tested positive for Isospora belli. Twenty days prior
to admission, biochemistry laboratory results were
normal. In the month before admission, his CD4
count was 103 cells/mm3 and viral load was
22,000 copies/ml. Urine was normal; there were
no traces of protein and no eosinophilia, hematuriaTable 1 Laboratory data.
Day Creatinine (mM) Urea (mM)
1 583 38.2
2 530 25.8
3 362 20.7
4 283 15.3
5 247 11.8
6 133 5.7
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doi:10.1016/j.ijid.2004.06.002or glycosuria. The patient had no direct signs of HIV
acute nephropathy, he had normal blood pressure
and normal levels of urea and creatinine. On admis-
sion, physical examination revealed a body tem-
perature of 37.8 8C, a pulse rate of 56 bpm, a
respiration rate of 27 breaths/min, and blood pres-
sure of 90/60 mmHg. Admission laboratory results
were: serum potassium 2.8 mM; serum magnesium
0.3 mM (normal 0.6—1.0 mM); serum creatinine
583 mM; blood urea 38.2 mM; pH 7.17; bicarbonate
2.4 mM (normal 22—26 mM); and lactate 2 mM (nor-
mal 0.5—2.2 mM) (Table 1). Increased serum chlor-
ide (119 mM, normal 95—105 mM) was also
registered. Urine analysis showed ++/++++ for pro-
tein. Ultrasound revealed normal-sized echogenic
kidneys.
Hydration was started with normal saline, and
bicarbonate, potassium and magnesium were
replaced. The antiretroviral drugs were inter-
rupted. Ciprofloxacin was prescribed for the diar-
rhea. A 24-hour peritoneal dialysis was performed
on the first day. On day two, diuresis increased. He
improved progressively and was discharged from the
intensive care unit six days after admission. The
serum sodium concentration, both during the inpa-
tient stay and prior to admission, was normal.
Potassium on day six was 3.0 mM and was supple-
mented with 100 to 150 mEq/day, but the patient
continued to experience diarrhea. The renal excre-
tion of potassium was normal. Sodium was adminis-
tered at the rate of 150 to 280 mEq per day, and
magnesium at 32 mEq/day. As an inpatient he
received sulfamethoxazole/trimethoprim 800/
160 mg, four times per day, for microbiologicallyPotassium (mM) Magnesium (mM)
2.8 0.3
2.4 0.3
3.3 0.5
3.2 0.5
3.5 0.7
3.0 0.8
es. Published by Elsevier Ltd. All rights reserved.
378 Letter to the EditorDehydration, hypokalemia, hypomagnesemia and
metabolic acidosis induced by diarrhea, were major
risk factors for the development of ARF in this
patient receiving antiretroviral therapy including
lamivudine, stavudine and efavirenz. Recovery of
renal function occurred concurrently with correc-
tion of the electrolyte and acid-base disturbances.
Recently, lamivudine and stavudine have been found
to be nephrotoxic. However, the nephrotoxicity
found in tests of stavudine and lamivudine may have
been associated with decompensated hyperlactate-
mia.4,5 Lactic acidosis did not occur in this case.
These data suggest that in order to avoid renal
toxicity, potassium and magnesium serum levels
should be carefully monitored in patients receiving
nucleoside analogues.
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